Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001104659-20-124024
Filing Date
2020-11-12
Accepted
2020-11-12 08:45:21
Documents
1
Period of Report
2020-11-09

Document Format Files

Seq Description Document Type Size
1 OWNERSHIP DOCUMENT tm2035660d1_3.html 3  
1 OWNERSHIP DOCUMENT tm2035660d1_3.xml 3 1547
  Complete submission text file 0001104659-20-124024.txt   3075
Mailing Address 200 CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS NJ 07922
Business Address 200 CONNELL DRIVE SUITE 1500 BERKELEY HEIGHTS NJ 07922 908-517-7330
Cyclacel Pharmaceuticals, Inc. (Issuer) CIK: 0001130166 (see all company filings)

EIN.: 911766850 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O PROTHENA CORPORATION PLC 650 GATEWAY BOULEVARD SOUTH SAN FRANCISCO CA 94080
Business Address
Walker Karin L (Reporting) CIK: 0001559422 (see all company filings)

Type: 3 | Act: 34 | File No.: 000-50626 | Film No.: 201303729